Gardner syndrome (Q46681): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Síndrome de Gardner desenvolve pólipos adenomatosos em todo o trato gastrointestinal, acompanhados por manifestações extracolônicas, incluindo adenomas periampulares, carcinoma papilar da tireoide, hepatoblastoma, osteomas de mandíbula e crânio, cistos epidérmicos e tumores desmoides. Síndrome de Gardner é um termo usado para se referir a pacientes nos quais essas características extraintestinais são excepcionalmente proeminentes. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Gardner syndrome develops adenomatous polyps throughout the gastrointestinal tract, accompanied by extracolonic manifestations, including periampullary adenomas, papillary carcinoma of the thyroid, hepatoblastoma, osteomas of the mandible and skull, epidermal cysts, and desmoid tumours. Gardner syndrome is a term used to refer to patients in whom these extraintestinal features are unusually prominent. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1428130769 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:LD2D.3 | |||||||||||||||
| Property / CURIE: CID11:LD2D.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-LD2D.3 | |||||||||||||||
| Property / Canary Token: dki-india-LD2D.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: Q85 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 15:26, 13 August 2026
Gardner syndrome develops adenomatous polyps throughout the gastrointestinal tract, accompanied by extracolonic manifestations, including periampullary adenomas, papillary carcinoma of the thyroid, hepatoblastoma, osteomas of the mandible and skull, epidermal cysts, and desmoid tumours. Gardner syndrome is a term used to refer to patients in whom these extraintestinal features are unusually prominent.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | LD2D.3 |
||
| English | Gardner syndrome |
Gardner syndrome develops adenomatous polyps throughout the gastrointestinal tract, accompanied by extracolonic manifestations, including periampullary adenomas, papillary carcinoma of the thyroid, hepatoblastoma, osteomas of the mandible and skull, epidermal cysts, and desmoid tumours. Gardner syndrome is a term used to refer to patients in whom these extraintestinal features are unusually prominent. |
Statements
CID11:LD2D.3
0 references
dki-india-LD2D.3
0 references
Concluído
0 references
13 August 2026
0 references
